Direct and Spillover Impacts of a Community-Level HIV/AIDS Program: Evidence from a Randomized Controlled Trial in Mozambique
Last registered on March 08, 2019

Pre-Trial

Trial Information
General Information
Title
Direct and Spillover Impacts of a Community-Level HIV/AIDS Program: Evidence from a Randomized Controlled Trial in Mozambique
RCT ID
AEARCTR-0003990
Initial registration date
March 08, 2019
Last updated
March 08, 2019 4:32 PM EST
Location(s)

This section is unavailable to the public. Use the button below to request access to this information.

Request Information
Primary Investigator
Affiliation
University of Michigan
Other Primary Investigator(s)
PI Affiliation
Beira Operational Research Center
PI Affiliation
University of Michigan
PI Affiliation
University of Michigan
Additional Trial Information
Status
On going
Start date
2017-01-01
End date
2020-12-31
Secondary IDs
Abstract
We study a prominent effort to help families cope with HIV/AIDS: a U.S. government-funded program in Mozambique implementing an interrelated set of health and education interventions. This study is the first randomized evaluation of a multifaceted, community-level program to combat HIV/AIDS. Primary outcome variables are directly-observed HIV testing and school attendance. We also examine a range of secondary outcomes from an endline household survey. Causal identification exploits multilevel random assignment (of communities to program receipt, and of treatment-community households to strong encouragement for program participation), allowing separate identification of impacts on households of being in a program community (with take-up at the community-average rate), versus having been strongly encouraged to participate the program (with very high take-up). We also examine spillovers (based on geographic proximity or social network connections) from strongly encouraged to other households. Additional treatments randomly assigned by our research team allow insight into informational and stigma mechanisms.
External Link(s)
Registration Citation
Citation
Mahumane, Arlete et al. 2019. "Direct and Spillover Impacts of a Community-Level HIV/AIDS Program: Evidence from a Randomized Controlled Trial in Mozambique." AEA RCT Registry. March 08. https://www.socialscienceregistry.org/trials/3990/history/42908
Experimental Details
Interventions
Intervention(s)
Intervention Start Date
2017-01-01
Intervention End Date
2020-12-31
Primary Outcomes
Primary Outcomes (end points)
We consider the two outcome variables that are directly observed by our project staff to be primary outcomes of interest:
1. HIV testing
2. School attendance
Primary Outcomes (explanation)
HIV testing: an indicator that at least one of a household’s HIV testing coupons has been redeemed. This is a household-level variable equal to 1 if at least one of a household’s incentive coupons is presented at the local health clinic for the HIV testing incentive payment before the 14-day deadline, and 0 otherwise.
School attendance: an indicator for a child attending school. This is an individual-level variable equal to 1 if a child is directly observed to be attending school by our project staff in an unannounced school visit, and 0 otherwise.
Secondary Outcomes
Secondary Outcomes (end points)
Secondary Outcomes (explanation)
Experimental Design
Experimental Design
The study uses a three-stage randomized controlled trial (RCT) methodology.
Stage 1: communities were randomly assigned to treatment or control status (inclusion in or exclusion from the FCC program).
Stage 2: a subset of households within FCC treatment communities were randomly assigned to a strong encouragement to participate in FCC programs (“directly enrolled” households). These directly enrolled households receive a home visit by an FCC program community worker and are assessed for inclusion in various FCC subcomponent programs.
Stage 3: as part of the endline survey, households in all communities (treatment and control) are randomly assigned to treatments to improve information about HIV, information about HIV treatment (antiretroviral therapy, or ART), and to reduce concerns about HIV-related stigma.
Experimental Design Details
Not available
Randomization Method
Randomization done in office by a computer
Randomization Unit
Stage 1: communities (38 treatment, 38 control)
Stage 2: households within FCC treatment communities
Stage 3: households in all communities
Was the treatment clustered?
Yes
Experiment Characteristics
Sample size: planned number of clusters
For Randomization Stage 1, 76 communities as clusters (38 treatment, 38 control).
Randomization Stages 2 and 3 are at the household level, not clustered.
Sample size: planned number of observations
76 communities as clusters (38 treatment, 38 control). 4,560 households across all communities.
Sample size (or number of clusters) by treatment arms
Randomization Stage 1: 76 communities as clusters (38 treatment, 38 control). 60 households in each community are included in survey sample.
Randomization Stage 2: 35 households in each treatment community randomly assigned to direct enrollment in FCC program; 25 in each treatment community are controls (not assigned to direct enrollment).
Randomization Stage 3: 25% of households assigned to each of four treatment conditions (HIV information, ART information, anti-stigma, and control).
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB
INSTITUTIONAL REVIEW BOARDS (IRBs)
IRB Name
University of Michigan Health Sciences and Behavioral Sciences Institutional Review Board
IRB Approval Date
2016-03-23
IRB Approval Number
HUM00113011
Analysis Plan

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information